SUMMARY
Infusion thrombophlebitis is a common problem in hospitalised patients. There have been several review articles dedicated to the subject.
I -3 The causes can be conveniently grouped into two main categories: infectious and non-infectious (or irritant).
Infectious thrombophlebitis occurs in up to 8% of intravenous catheterizations, the risk increasing with duration of cannulation. 1,3-6 Those peripheral intravenous catheters that are left in situ for greater than 72 hours are associated with a septicaemia rate of 2_5%.3,4,6 As in many institutions, our hospital has a policy of removing or changing peripheral intravenous catheters after 48 hours. However, as is also the case in other institutions, many are left in situ for a longer period.
Recent studies suggest that the catheter hub is the major source of bacteria in catheter contamination. 7 Bacteria may also migrate down the interface of the skin and catheter itself, or contaminate the catheter tip at the time of insertion (despite routine skin preparation). [8] [9] [10] demonstrated a significant reduction of glove and catheter contamination employing an iodophorimpregnated sterile film before central venous catheterization. Thus the needle and catheter were passed directly through the sterile film, and a second film placed over the site. Interestingly, there is conflicting evidence concerning the value of occlusive dressings in the reduction of thrombophlebitis. 2, 10, 13, 14 The factors that predispose to irritant thrombophlebitis are well described. 1-6,8.10,15.16 Recently Gaukroger et a!. 5 found that the nature of the cannula material was a significant factor, with Vialon® ('Insyte', Deseret Medical Inc., Utah, U.S.A.) being associated with a significantly lower thrombophlebitis rate than Teflon® ('Jelco', Critikon Inc., Aust.). Sexton et at. (personal communication, 1989) found no difference in another recent study. We have been using Teflon® cannulae predominantly at our hospital for many years. The manufacturers of this product (Critikon Inc., Aust.) claim their new Teflon® ('Jelco-striped') cannula, with bismuth-oxide stripes, has superior characteristics.
The aim of this investigation was to prospectively evaluate a double-occlusive dressing technique when compared to a standard singleocclusive dressing for peripheral intravenous catheterisations, and to compare the new Teflon® ('Jelco-striped') cannula versus the current Vialon® ('Insyte') cannula.
MATERIALS AND METHODS
Two hundred elective patients, who were expected to require a 16 gauge peripheral intravenous cannula for greater than 24 hours, were included in the study. All intravenous cannulae were inserted in theatre, by trainee and specialist anaesthetists. The anaesthetist was free to choose the site of insertion in the upper limb: arm, forearm, or hand. Patients were excluded if there was prior evidence of sepsis and if the peripheral intravenous cannula was removed before 24 hours (due to inability to accurately grade thrombophlebitis and collect cannulae tips for culture). Re-sited cannulae were not analysed. ' Patients were randomised into one of four groups ( Table 2) . Group 1 received a 16 gauge 57 mm Teflon® cannula ('Jelco', Critikon Inc., Aust.) with a single-occlusive dressing. Group 2 received a 16 gauge 57 mm Teflon® cannula with a doubleocclusive dressing. Group 3 received a 16 gauge 51 mm Vialon® ('Insyte', Deseret Medical Inc., Utah, USA) with a single-occlusive dressing. Group 4 received a 16 gauge 51 mm Vialon® cannula with a double-occlusive dressing. All patients received the same skin preparation, consisting of 0.5% chlorhexidine in 70% ethanol, followed 60 seconds later by skin infiltration (25 gauge needle) with procaine 2%. After cannulation, groups 1 and 3 had a single polyurethane occlusive dressing (OpSite®, Smith and Nephew, Aust.) applied in such a way as to cover the skin entry site and hub of the cannula. Groups 2 and 4 had the first polyurethane occlusive OpSite® dressing applied to the intended insertion site, and the intravenous cannula was then inserted directly through the first dressing. A second occlusive dressing was then applied in such a way as to cover the entry site and hub of the cannula ( Figure 1 ). All intravenous lines were secured using a standard technique of adhesive tape over the distal segment of intravenous tubing looped back up the limb, and a second tape over the intravenous tubing and proximal edge of polyurethane film.
The anaesthetist was asked to score the degree of difficulty of insertion with each cannulation on a scale of 0 to 5 (easy to most difficult). A record was made of any anaesthetic agents injected through the study cannula. Management of the peripheral intravenous therapy and use of intravenous drugs was left to the attending medical staff. All intravenous fluids and drugs that were used in the ensuing days were documented. Additional data collected included patient age, sex, and type of surgery.
The insertion sites were inspected daily by one of the authors. The degree of thrombophlebitis was scored using the scale described by Dinleyl7 (Table  1) , which takes into account pain, erythema, tenderness, and induration. The deci~n to remove the intravenous cannula was left to the medical and nursing staff looking after the patient. Following removal, the cannulae were placed in a sterile container, and sent for culture employing the semiquantitative technique of Maki. 4 Cannula tip infection was defined as fifteen or more colonyforming units by Maki technique. If overt infection was present at the insertion site, it was cultured separately. A note was made during the postoperative assessments if the patient had clinical evidence of bacteraemia. The duration of cannulation was calculated.
Comparison between the cannulae was achieved by combining the single and double occlusive dressing groups, and the comparison between the occlusive dressings was achieved by combining the separate cannula groups. This ensured equal characteristics of the groups and improved the power of statistical testing. Using previously published data,S with an expected difference of means of 0.5 and standard deviation of 1.0, we calculated a power of 0.8 required approximately 200 subjects. The significance of differences was determined using the Chi-squared test (with Yates' correction) for cannula tip cultures, and unpaired Student's t-test for duration of cannulation, degree of difficulty and insertion and thrombophlebitis score. The use of a parametric test (t-test) to analyse ordinal data was considered valid due to the large numbers involved. Confidence intervals were calculated where appropriate.
RESULTS
A total of 193 intravenous cannulae were inserted and evaluated daily till removal (Table 2) . Seven patients were excluded from evaluation due to unexpected early removal (before 24 hours). There were 40 patients in group 1, 48 patients in group 2, 53 patients in group 3, and 52 patients in group 4, The effect of drugs, type of fluid administered and type of surgery were not analysed separately, as these factors have been evaluated previously, 5, 10, 15 The mean duration of cannulation was 46.4 hours, with a mean thrombophlebitis score of 0.25 on day 1, 0.8 on day 1, 1.1 on day 3, and 0.9 on day 4. No patient had a thrombophlebitis score of 5 (overt infection). The reason for removal of the intravenous cannulae was not recorded as it was often ill-defined or multifactorial. There was no difference with difficulty of insertion, despite prior application of an occlusive dressing (Table 3) .
There was no statistically significant difference in the duration of cannulation, comparing Teflon® and Vialon®. However, the use of a doubleocclusive dressing was associated with a significant increase in the duration of cannulation: 50.9 hours Table 4) .
The results of cannulae tip culture were no different between Teflon® and Vialon®, nor singleand double-occlusive dressing techniques ( Table  5 ). The most common organism grown was Staphylococcus epidermidis; however, Serratia marcescens, Staphylococcus aureus and other skin flora were also cultured. No patient developed clinical evidence of bacteraemia secondary to intravenous cannulation.
Vialon® was found to be superior to Teflon® using a modification of Dinley's thrombophlebitis score. 17 This did not reach statistical significance in the initial 24 hours, but the difference was significant on days 2, 3 and 4. The use of a doubleocclusive dressing technique did not decrease the incidence of thrombophlebitis (Table 6) . DISCUSSION We undertook this study to evaluate two factors: cannula material and the value of a doubleocclusive dressing technique. Teflon® cannulae have been routinely used at our hospital; Gaukroger et a/. 5 found that Vialon® had superior characteristics (ease of insertion, lower thrombophlebitis scores). However, Critikon Australia, the manufacturer of Teflon® ('Je1co') have released a new version of cannula on the market, which we felt deserved evaluation. It is clear from our study (Table 6) , that despite the (P=NS) modifications to the Teflon® ('Jelco') cannula, Vialon® remains superior in the conditions of this study: experienced operators, clean theatre environment, adequate skin preparation with antiseptic, occlusive dressing and secure taping (fixation) of the cannula and IV tubing to prevent movement at the insertion site.
Factors affecting infusion thrombophlebitis have been well described. Duration of cannulation remains the prime determinant. A policy of daily inspection of cannulation site and routine replacement after 48 hours (unless removal expected within the next 24 hours) is our recommendation. Earlier removal should occur if evidence of thrombophlebitis exists: pain, tenderness, redness, swelling. However, situations exist where such frequent changing may be difficult such as in paediatric patients and patients with poor peripheral venous access. In such situations, it may be reasonable to minimize aggravating factors and use a suitable Vialon® cannula. Naturally the insertion site should be inspected daily and the cannula removed if thrombophlebitis develops. As in Gaukroger's study, 5 several patients in our study were free of thrombophlebitis for up to eight days.
Our study was not designed to accurately assess duration of cannulation, due to the ill-defined nature of the decision to remove the cannulae. However, we felt duration of cannulation was a useful clinical parameter when investigating thrombophlebitis, and could be used to compare ). Although our study implies a negative effect of a double-occlusive dressing on day 4 (thrombophlebitis score of 0.3 vs 1.3), the numbers were too small to accurately represent the time situation. The use of the parametric Student's t-test is invalid with such small numbers, using ordinal data. This study showed that skin flora (especially Staphylococcus epidermidis) can be cultured from the cannula tips on removal. A positive result was obtained in 6% (11 from 183) of cannula tip cultures. This is a lower incidence than in other studies. 4 ,8 Thrombophlebitis occurred much more frequently and highlights that infusion thrombophlebitis is most often a sterile inflammatory process. This may explain the ineffectiveness of the double-occlusive dressing technique. No clinical evidence of bacteraemia occurred in our group of 200 patients.
Despite Vialon® cannulae being relatively new to our department, the overall ease of insertion was no different from the familiar Teflon®. Prior application of OpSite® did not make cannulation more difficult.
In conclusion, 16 gauge Vialon® cannulae were associated with a lower incidence of infusion thrombophlebitis than the new striped 16 gauge Teflon® cannulae, and the use of a doubleocclusive dressing did not decrease the incidence of infusion thrombophlebitis.
